Financials data is unavailable for this security.
View more
Year on year TATA Health International Holdings Ltd has grown net income from a loss of 60.76m to a gain of 9.61m despite declining revenues.
Gross margin | 79.16% |
---|---|
Net profit margin | -15.00% |
Operating margin | -13.18% |
Return on assets | -15.16% |
---|---|
Return on equity | -67.65% |
Return on investment | -55.53% |
More ▼
Cash flow in HKDView more
In 2022, TATA Health International Holdings Ltd increased its cash reserves by 25.82%, or 6.91m. The company earned 13.01m from its operations for a Cash Flow Margin of 8.99%. In addition the company generated 7.93m cash from investing, though they paid out 13.97m more in financing than they received.
Cash flow per share | -0.0647 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0932 |
---|---|
Tangible book value per share | 0.0932 |
More ▼
Balance sheet in HKDView more
Current ratio | 0.6201 |
---|---|
Quick ratio | 0.4279 |
Total debt/total equity | 2.60 |
---|---|
Total debt/total capital | 0.8983 |
More ▼